Your browser doesn't support javascript.
loading
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.
Studt, J-D; Alberio, L; Angelillo-Scherrer, A; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, M.
Afiliação
  • Studt JD; Division of Haematology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Alberio L; Service and Central Laboratory of Haematology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Angelillo-Scherrer A; Department of Haematology, Inselspital, Bern University Hospital, Berne, Switzerland.
  • Asmis LM; Department of Clinical Research, University of Bern, Berne, Switzerland.
  • Fontana P; Unilabs Zurich, Zurich, Switzerland.
  • Korte W; Division of Angiology and Haemostasis, University Hospitals of Geneva, Geneva, Switzerland.
  • Mendez A; Institute for Clinical Chemistry and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Schmid P; Centre for Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Stricker H; Division of Haematology and Central Haematology Laboratory, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Tsakiris DA; Division of Surgery, Regional Hospital La Carita, Locarno, Switzerland.
  • Wuillemin WA; Diagnostic Haematology, University Hospital of Basel, Basel, Switzerland.
  • Nagler M; Division of Haematology and Central Haematology Laboratory, Luzerner Kantonsspital, Lucerne, Switzerland.
J Thromb Haemost ; 15(8): 1576-1583, 2017 08.
Article em En | MEDLINE | ID: mdl-28574652

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Fator Xa / Monitoramento de Medicamentos / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Fator Xa / Monitoramento de Medicamentos / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article